Clinical Trial

The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-01-20; most recent amendment 2026-06-02.
Status change: Not Yet Recruiting → Recruiting 2023-10-31
Trial Details
NCT Number NCT05218850
Lead Sponsor Children's Hospital Los Angeles
Conditions Ulcerative Colitis
Enrollment 10 participants
Start Date 2022-06-29
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-04